Skip to main content
Ignition Insights
From “Can We Innovate?” to “How Can We Sustain Innovation?”: How Ignition Research Reconstructs Enterprise R&D Pathways
Stop viewing innovation as a risk. Learn how Ignition Research helps enterprises transform daily operational improvements into structured, sustainable R&D pathways.
R&DTI Compliance Guide: Practical Essentials for Successful R&D Tax Claims
Discover key compliance essentials for Australia's R&D Tax Incentive (R&DTI). Learn how to document R&D activities, link costs, and reduce claim risks with practical case studies.
Can I Claim a Seed-Start Grant and the R&D Tax Incentive?
Can you claim a Seed-Start or RCSF grant and the federal R&D Tax Incentive? Yes — but watch clawback. How SA founders stack state grants cleanly.
ATO Audit Focus Revealed: Compliance Risk Management Under the R&D Tax Incentive
Learn which R&D Tax Incentive areas the ATO scrutinises in audits, from technical uncertainty to overseas spend and records, and how to cut risk.
Grants and the R&D Tax Incentive: how clawback stops the "double dip"
Can you claim a government grant and the R&D Tax Incentive together? Yes — but a clawback adjustment may apply. How recoupment works, with an example.
Clinical trials, biotech and medtech: how the R&D Tax Incentive applies
Are clinical trials eligible for the R&D Tax Incentive? How biotech, medtech and preclinical work qualify, overseas trials, and the records you need.
Feedstock and at-risk adjustments: a plain-English worked example
What a feedstock adjustment is, how the one-third-of-the-lesser rule works, and how the at-risk rule differs — with a manufacturing worked example.
Tax Optimisation Strategies for Global R&D Collaboration: A Comprehensive Guide to International R&DTI Planning
How Australian firms running cross-border R&D can plan for the R&DTI, meet Overseas Finding rules, and keep eligible expenditure well documented.
Beyond RSP: How Ignition Research is Redefining the Value of R&D Services
How a strategic RSP approach turns everyday business problems into defensible, self-assessed R&D activities, beyond retrospective compliance claims.